An update on solid-state characterization of the polyphenol pterostilbene

McCormack, 2013, A review of pterostilbene antioxidant activity and disease modification, Oxid. Med. Cell. Longev., 2013, 10.1155/2013/575482 Lin, 2020, Occurrence, bioavailability, anti-inflammatory, and anticancer effects of pterostilbene, J. Agric. Food Chem., 68, 12788, 10.1021/acs.jafc.9b07860 Tsai, 2017, Biological actions and molecular effects of resveratrol, pterostilbene, and 3 '-hydroxypterostilbene, J. Food Drug Anal., 25, 134, 10.1016/j.jfda.2016.07.004 Koh, 2021, Recent advances in health benefits of stilbenoids, J. Agric. Food Chem., 69, 10036, 10.1021/acs.jafc.1c03699 Kim, 2020, Chemistry of pterostilbene and its metabolic effects, J. Agric. Food Chem., 68, 12836, 10.1021/acs.jafc.0c00070 Riche, 2013, Analysis of safety from a human clinical trial with pterostilbene, J. Toxicol., 2013, 10.1155/2013/463595 Savjani, 2012, Drug solubility: importance and enhancement techniques, ISRN Pharmaceutics, 2012, 1, 10.5402/2012/195727 Lang, 2013, Polymorph screening of an active material, J. Pharmaceut. Biomed. Anal., 84, 177, 10.1016/j.jpba.2013.06.002 Szabo, 2016, The role of solid state characterization in predicting stability of solid dosage forms, Curr. Pharmaceut. Des., 22, 5019, 10.2174/1381612822666160726094236 Rodriguez-Aller, 2015, Strategies for formulating and delivering poorly water-soluble drugs, J. Drug Deliv. Sci. Technol., 30, 342, 10.1016/j.jddst.2015.05.009 Sorrenti, 2012, Solid-state characterization of tacrine hydrochloride, J. Pharmaceut. Biomed. Anal., 63, 53, 10.1016/j.jpba.2011.12.023 Mahesh, 2010, 1 Gottumukkala, 2013, 1 Rossi, 2013, Scavenging of hydroxyl radical by resveratrol and related natural stilbenes after hydrogen peroxide attack on DNA, Chem. Biol. Interact., 206, 175, 10.1016/j.cbi.2013.09.013 Bofill, 2019, Hydrogen bond polarization overcomes unfavorable packing in the most stable high Z ' polymorph of pterostilbene, Cryst. Growth Des., 19, 2552, 10.1021/acs.cgd.9b00374 Bofill, 2020, A late appearing polymorph of nutraceutical pterostilbene, CrystEngComm, 22, 4680, 10.1039/D0CE00837K Sree Rambabu, 2013, 1 Schultheiss, 2010, Nutraceutical cocrystals: utilizing pterostilbene as a cocrystal former, CrystEngComm, 12, 2436, 10.1039/c002045a Bethune, 2011, Improving the poor aqueous solubility of nutraceutical compound pterostilbene through cocrystal formation, Cryst. Growth Des., 11, 2817, 10.1021/cg1016092 Bofill, 2021, A novel, extremely bioavailable cocrystal of pterostilbene, Cryst. Growth Des., 21, 2315, 10.1021/acs.cgd.0c01716 Aaltonen, 2008, Perspectives in the use of spectroscopy to characterise pharmaceutical solids, Int. J. Pharm., 364, 159, 10.1016/j.ijpharm.2008.04.043 Threlfall, 2000, Crystallisation of polymorphs: thermodynamic insight into the role of solvent, Org. Process Res. Dev., 4, 384, 10.1021/op000058y Kitamura, 2009, Strategy for control of crystallization of polymorphs, CrystEngComm, 11, 949, 10.1039/b809332f Cruz, 2019, Application of selective crystallization methods to isolate the metastable polymorphs of paracetamol: a review, Org. Process Res. Dev., 23, 2592, 10.1021/acs.oprd.9b00322